Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02764541
Title Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib

Palbociclib + Tamoxifen

Letrozole

Tamoxifen

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stamford Hospital Stamford Connecticut 06904 United States Details
Eastern Maine Medical Center Brewer Maine 04412 United States Details
Dana-Farber at St. Elizabeth's Medical Center Boston Massachusetts 02135 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
DF/BWCC at Milford Regional Medical Center Milford Massachusetts 01757 United States Details
DF/BWCC in clinical affiliation with South Shore Hospital South Weymouth Massachusetts 02190 United States Details
Lifespan Providence Rhode Island 02903 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field